Envestnet Asset Management
EWTX icon

Envestnet Asset Management’s Edgewise Therapeutics EWTX Stock Holding History

Envestnet Asset Management’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$922K Buy
22,685
+6,955
+44% +$240K ﹤0.01% 3676
2026
Q1 		$495K Buy
+15,730
New +$454K ﹤0.01% 3941
2025
Q4 		– Sell
-10,837
Closed -$176K – 4525
2025
Q3 		$176K Buy
+10,837
New +$154K ﹤0.01% 4348
2025
Q2 		– Sell
-15,399
Closed -$339K – 4472
2025
Q1 		$339K Buy
15,399
+721
+5% +$18.9K ﹤0.01% 3856
2024
Q4 		$392K Buy
14,678
+3,561
+32% +$113K ﹤0.01% 3731
2024
Q3 		$297K Buy
+11,117
New +$221K ﹤0.01% 3831

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Envestnet Asset Management's EWTX Position: Q2 2026 in Review

Envestnet Asset Management increased its Edgewise Therapeutics (EWTX) stake by 44% in Q2 2026, buying an estimated $240K and bringing the position to 22,685 shares worth $922K. The position accounts for ﹤0.01% of the portfolio, ranked #3676.

Envestnet Asset Management first reported a position in EWTX in Q3 2024 and has held it in 6 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Envestnet Asset Management held 22,685 shares of Edgewise Therapeutics worth $922K as of Q2 2026.
  • Envestnet Asset Management bought 6,955 Edgewise Therapeutics shares in Q2 2026, an estimated $240K.
  • Edgewise Therapeutics made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3676 holding.
  • Envestnet Asset Management first reported a position in Edgewise Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.